You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
微創機器人-B(02252.HK):鴻鵠®骨科手術機器人獲批上市

格隆匯4月21日丨微創機器人-B(02252.HK)宣佈,公司全資附屬公司蘇州微創暢行機器人有限公司自主研發的鴻鵠®骨科手術機器人("鴻鵠®")獲得國家藥品監督管理局的上市批准。鴻鵠®成為了第一款,也是截至目前唯一一款搭載中國企業自主研發,自有知識產權機械臂,並獲准上市的骨科手術機器人。

據悉,鴻鵠®是集團自主研發,專為關節置換手術而設計的骨科手術機器人,其輔助下全膝關節置換手術,具有個性精準、高效協同、安全保護和相容性強等眾多技術優勢。與傳統手術相比,鴻鵠®術前協助醫生制定個性化手術方案,術中輔助操作,降低手術對醫生經驗的依賴,且術中無髓內杆植入,降低患者的手術損傷,改善術後下肢力線,減少手術併發症,幫助患者實現術後快速康復。

作為公司第三款獲批上市的旗艦產品,鴻鵠®開啟了我們在骨科賽道全面佈局的新篇章。鴻鵠®上市後,公司將通過各類臨牀教育培訓和服務,全方位助力優質醫療資源的普及和下沉,為更多骨科疾病患者提供更精準、更智慧、更普惠的關節置換解決方案,進一步推動中國智慧骨科的蓬勃發展。同時,我們正在設計開發應用於全髖關節置換術的鴻鵠®產品,並計劃於2022年於中國開展臨牀試驗。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account